Landscapes / Companies
Stemline Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
1 in Phase 2
Drugs
4
in active trials · 8 in all
Trials
9 active
21 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Estrogen receptor antagonist |
Approved | Nov 2026soonPhase 2 trial completes | |||
| How it works | Blocks oestrogen from acting on cells | ||||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Breast Cancer, Metastatic Breast Cancer and 9 more | ||||
| Open drug page | |||||
CD123 Interaction; cytotoxin |
Approved | 9 Feb 2028Phase 2 trial completes | |||
| Next date | 9 Feb 2028 · Phase 2 trial completes | ||||
| Also tested for | Acute Myeloid Leukemia | ||||
| Open drug page | |||||
— |
Phase 1/2 | 12 May 2028Phase 1/2 trial completes | |||
| Next date | 12 May 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Breast Cancer, Hematological Malignancy | ||||
| Open drug page | |||||
— |
Phase 1 | 2 Dec 2027Phase 1 trial completes | |||
| Next date | 2 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Platinum-resistant Ovarian Cancer | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021